Pasar saham, bursa saham dinten
harga Bagikeun of 71229 pausahaan sacara real waktu.
Pasar saham, bursa saham dinten

Tanda petik stock

Stock tanda petik Online

Sajarah harga saham

dimodalan pasar saham

Dividends on biasa

Untung ti biasa dina pausahaan

laporan keuangan

Peunteun pausahaan. Dimana pikeun investasi?

Nilai biasa GlaxoSmithkline Pharmaceuticals Limited

Biasa Exchange GlaxoSmithkline Pharmaceuticals Limited kiwari, nu harga saham, GLAXO.BO anu ayeuna online, dina harga saham, GlaxoSmithkline Pharmaceuticals Limited.
nambahkeun widget
Dipasang dina widget
GLAXO.BO = 1 244.65 Rupia India
-3.75 INR (-0.3013%)
ngarobah di nilai tina biasa saprak kamari

Harga stock saham harga gaduh nilai rata-rata per dinten. Pasar Crypto terlibat dina mindahkeun GlaxoSmithkline Pharmaceuticals Limited inin Rupia India. Inpormasi laju harga saham diénggalan. 1 saham tina GlaxoSmithkline Pharmaceuticals Limited ayeuna 1 244.65 saham tina Rupia India. GlaxoSmithkline Pharmaceuticals Limited suku ragrag ti saprak kamari. Kelas GlaxoSmithkline Pharmaceuticals Limited laju turun ngalawan Rupia India ku -30 ratus-an tina titik persentase.

Tembongkeun:
Ka

GlaxoSmithkline Pharmaceuticals Limited nilai dibagikeun dina pausahaan Rupia India

Saminggu ka tukang, GlaxoSmithkline Pharmaceuticals Limited tiasa disilihtukeurkeun pikeun 1 244.60 Rupia India. Tilu bulan ka tukang, GlaxoSmithkline Pharmaceuticals Limited tiasa disilihtukeurkeun pikeun 0 Rupia India. Tilu taun ka pengker, GlaxoSmithkline Pharmaceuticals Limited bisa dibeli pikeun 1 461 Rupia India. Parobihan harga saham tina GlaxoSmithkline Pharmaceuticals Limited dina Rupia India kanggo saminggu nyaéta 0%. 0% sabulan - perobihan harga saham tina GlaxoSmithkline Pharmaceuticals Limited. 0% per taun - perobihan harga saham GlaxoSmithkline Pharmaceuticals Limited.

minggu Sasih 3 bulan taun 3 taun

Tanda petik stock GlaxoSmithkline Pharmaceuticals Limited Rupia India

GLAXO.BO Ka Rupia India (INR)
1 GLAXO.BO 1 244.65 Rupia India
5 GLAXO.BO 6 223.25 Rupia India
10 GLAXO.BO 12 446.50 Rupia India
25 GLAXO.BO 31 116.25 Rupia India
50 GLAXO.BO 62 232.50 Rupia India
100 GLAXO.BO 124 465 Rupia India
250 GLAXO.BO 311 162.50 Rupia India
500 GLAXO.BO 622 325 Rupia India

Konverter kutipan saham ayeuna kanggo 10 saham tina GlaxoSmithkline Pharmaceuticals Limited masihan 12 446.50 Rupia India. Anjeun tiasa ngajual 31 116.25 Rupia India pikeun 25 saham tina GlaxoSmithkline Pharmaceuticals Limited. Dinten ieu, anjeun tiasa ngarobih 50 saham GlaxoSmithkline Pharmaceuticals Limited kanggo 62 232.50 Rupia India. Anjeun tiasa ngajual 100 saham tina GlaxoSmithkline Pharmaceuticals Limited pikeun 124 465 Rupia India. Dinten ayeuna, 250 saham tina GlaxoSmithkline Pharmaceuticals Limited tiasa dibeli pikeun 311 162.50 Rupia India. Upami anjeun ngagaduhan 622 325 Rupia India, maka dina India aranjeunna tiasa dijual pikeun 500 saham tina GlaxoSmithkline Pharmaceuticals Limited.

GLAXO.BO sajarah ngeunaan harga saham

Kaping Meunteun Ngarobah
04/05/2023 1 244.650 INR -3.75 ↓
03/05/2023 1 248.400 INR 17.5 ↑
02/05/2023 1 230.900 INR -10.9 ↓
28/04/2023 1 241.800 INR -2.8 ↓
27/04/2023 1 244.600 INR -

1 saham tina GlaxoSmithkline Pharmaceuticals Limited dina Rupia India ayeuna aya dina 4 Mei 2023 - 1 244.650 Rupia India. 3 Mei 2023, 1 saham tina GlaxoSmithkline Pharmaceuticals Limited = 1 248.400 Rupia India. 2 Mei 2023, 1 saham tina GlaxoSmithkline Pharmaceuticals Limited = 1 230.900 Rupia India. Maksimum maksimal GLAXO.BO / INR suku di dina 03/05/2023. GlaxoSmithkline Pharmaceuticals Limited dina Rupia India dina 27 April 2023 sami sareng 1 244.600 Rupia India.

GlaxoSmithkline Pharmaceuticals Limited

Hiji babagi tina GlaxoSmithkline Pharmaceuticals Limited dinten téh 1 244.65 Rs. Bagikeun harga GLAXO.BO robah jadi -0.3013% atawa -3.75 INR ti dinten dagang saméméhna. Anjeun bisa meuli 100 biasa tina GlaxoSmithkline Pharmaceuticals Limited kanggo 124 465 Rupia India, atawa ngajual 50 biasa tina GLAXO.BO kanggo 62 232.50 Rupia India.

Nilai biasa GlaxoSmithkline Pharmaceuticals Limited

Keuangan GlaxoSmithkline Pharmaceuticals Limited

Loading ...
Loading ...